The telemedicine market was previously valued at $60.9 billion in 2021. This surge over the next decade is expected due to the increasing demand of telehealth services, fueled by its cost benefits and the growing prevalence of chronic illnesses.
The market report also considers restraints to the growing industry, including healthcare fraud. Fraudulent telehealth activities by providers could have a potential negative impact on the market’s credibility, the report said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.